CLASSIFICATION
Glycoprotein Cytokine
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Drogsan
WAREHOUSE
International Warehouse 2
SUBSTANCE
Erythropoietin
,
Dropoetin is prescribed for managing anemia linked to chronic kidney failure in both pediatric and adult patients undergoing hemodialysis or peritoneal dialysis.
It is also indicated for treating severe renal-derived anemia with clinical symptoms in adults who have renal insufficiency but are not yet on dialysis.
Additionally, Dropoetin is utilized to treat anemia and reduce the need for transfusions in adult cancer patients (with non-myeloid malignancies) undergoing chemotherapy.
In HIV-infected adults receiving zidovudine treatment and exhibiting endogenous Dropoetin levels of ≤500 mU/ml, Dropoetin is indicated for anemia management.
For adults with moderate anemia (hematocrit levels of 33-39%, hemoglobin levels of 10-13 g/dL, no iron deficiency), scheduled for major elective surgery and expected to require more blood than can be collected via autologous methods, Dropoetin is recommended to aid in autologous blood collection and minimize the risk of allogeneic blood transfusions. Treatment should only occur if blood conservation methods are inadequate for surgeries anticipated to require a significant volume of blood (4 or more units for females or 5 or more units for males).
Dropoetin is also indicated to enhance erythropoiesis during the perioperative period to decrease the likelihood of allogeneic blood transfusions and correct postoperative anemia in adult patients without iron deficiency undergoing major elective orthopedic surgeries. This use is limited to patients with moderate anemia (e.g., Hb 10-13 g/dL) who lack access to autologous predonation programs and are expected to experience moderate blood loss (900 to 1800 ml).
Finally, Dropoetin is indicated for treating anemia in patients with Low or Intermediate 1-risk Myelodysplastic Syndrome (MDS), specifically those with hemoglobin levels below 10 g/dL.
Using Dropoetin:Administer Dropoetin as prescribed by your healthcare provider. Check the medication label for exact dosing instructions.
An additional patient information leaflet, called a Medication Guide, accompanies Dropoetin; make sure to read it thoroughly and refer to it again each time you refill your prescription.
Dropoetin is generally administered through injection at a doctor's office, hospital, or clinic. If you plan to use Dropoetin at home, a healthcare professional will instruct you on its proper use, and it is crucial to understand the procedure. Always follow the guidelines provided to you when taking your dose, and contact your healthcare provider with any inquiries.
When preparing a dose, adhere to the techniques demonstrated to prevent contamination of the vial, syringe, or medication. Avoid touching the rubber stopper of the vial or the syringe needle with your fingers.
Always verify that you have drawn the correct dose prior to administration.
Do not shake Dropoetin, and do not use it if it has been shaken or frozen.
Do not dilute or mix Dropoetin with other solutions unless directed by your physician.
If using a single-dose vial, dispose of any unused medication once your dose has been taken. Consult with your doctor, pharmacist, or healthcare provider if you have questions regarding single-dose vials.
Do not use Dropoetin if it appears cloudy, discolored, contains particles, or if the vial is damaged or cracked.
Store Dropoetin along with syringes and needles away from the reach of children and pets. Never reuse needles, syringes, or other supplies. Inquire with your healthcare provider about the correct disposal methods for these items, and follow all local disposal regulations.
Continue to take Dropoetin even if you feel well, and ensure you do not miss any doses. If you miss a dose, contact your doctor as soon as possible.
Feel free to reach out to your healthcare provider with any questions regarding the use of Dropoetin.
Dropoetin Side Effects:The following serious adverse effects are covered in more detail in other sections of the label: